Partners & Alliances   Print Screen

The QuantRx business strategy is centered around three principles, as follows:

  • To commercialize products through partners or distributors.

  • To contract manufacture with third parties while maintaining control over the manufacturing process.

  • To assume responsibility for the development of the products and their conformity to U.S. regulatory requirements.

QuantRx's partnership with Procter & Gamble is a multiyear, multimillion-dollar licensing agreement that allows QuantRx to incorporate patented P&G technology into QuantRx PAD technology-based products for a number of healthcare markets. The Company has also entered into an important development agreement with ALT BioScience.


About Procter & Gamble:

Three billion times a day, P&G brands touch the lives of people around the world. The company has one of the strongest portfolios of trusted, quality, leadership brands, including Pampers®, Tide®, Ariel®, Always®, Whisper®, Pantene®, Mach3®, Bounty®, Dawn®, Pringles®, Folgers®, Charmin®, Downy®, Lenor®, Iams®, Crest®, Oral-B®, Actonel®, Duracell®, Olay®, Head & Shoulders®, Wella®, Gillette®, and Braun®.

A.G. Lafley, Chairman of the Board, President and CEO of the Procter & Gamble Company, says, “We've collaborated with outside partners for generations - but the importance of these alliances to P&G has never been greater. Our vision is simple. We want P&G to be known as the company that collaborates - inside and out - better than any other company in the world. I want us to be the absolute best at spotting, developing, and leveraging relationships with best-in-class partners in every part of our business. In fact, I want P&G to be a magnet for the best-in-class. The company you most want to work with because you know a partnership with P&G will be more rewarding than any other option available to you.”

About ALT BioScience, LLC:

ALT BioScience, LLC is a specialty bioscience company that discovers, develops, and commercializes diagnostic and biomedical technologies focused on oral-systemic health, neurodegenerative diseases, and nucleotide photoaffinity labeling for basic protein research. Nucleotide photoaffinity labeling is the foundation of the company and a research tool for nearly 300 research, biotech, and pharmaceutical companies worldwide which allows for the identification of enzyme-protein differences in diseases such as Alzheimer's, ALS, and cancer. Founded in 1997, ALT BioScience, LLC, is a privately held company located in Lexington, Kentucky.

© Copyright 2007 - QuantRx® Biomedical Corporation